Emerging incretin (glucagon-like peptide-1)-derived therapies for type 2 diabetes
Glucagon-like peptide-1 in type 2 diabetes: the -cell and beyond
Nauck, Michael A.
The physiology and pharmacology of incretins in type 2 diabetes mellitus
Holst, Jens J.
Glucagon-like peptide-1-based therapies: new developments and emerging data
Garber, Alan J.